MeCP2 binds to the promoter region of PCDH7 and downregulates its mRNA level, suggesting that the dysregulation of these molecules may be related to the neuronal and synaptic dysfunction observed in the brains of patients with Rett syndrome [54]. Here, MECP2 is linked to atypical Rett syndrome.